Vector-model-supported optimization in volumetric-modulated arc stereotactic radiotherapy planning for brain metastasis.

Journal: Medical dosimetry : official journal of the American Association of Medical Dosimetrists
Published Date:

Abstract

Long planning time in volumetric-modulated arc stereotactic radiotherapy (VMA-SRT) cases can limit its clinical efficiency and use. A vector model could retrieve previously successful radiotherapy cases that share various common anatomic features with the current case. The prsent study aimed to develop a vector model that could reduce planning time by applying the optimization parameters from those retrieved reference cases. Thirty-six VMA-SRT cases of brain metastasis (gender, male [n = 23], female [n = 13]; age range, 32 to 81 years old) were collected and used as a reference database. Another 10 VMA-SRT cases were planned with both conventional optimization and vector-model-supported optimization, following the oncologists' clinical dose prescriptions. Planning time and plan quality measures were compared using the 2-sided paired Wilcoxon signed rank test with a significance level of 0.05, with positive false discovery rate (pFDR) of less than 0.05. With vector-model-supported optimization, there was a significant reduction in the median planning time, a 40% reduction from 3.7 to 2.2 hours (p = 0.002, pFDR = 0.032), and for the number of iterations, a 30% reduction from 8.5 to 6.0 (p = 0.006, pFDR = 0.047). The quality of plans from both approaches was comparable. From these preliminary results, vector-model-supported optimization can expedite the optimization of VMA-SRT for brain metastasis while maintaining plan quality.

Authors

  • Eva Sau Fan Liu
    Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong.
  • Vincent Wing Cheung Wu
    Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong.
  • Benjamin Harris
    Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia.
  • Matthew Foote
    Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia; School of Medicine, University of Queensland, Australia.
  • Margot Lehman
    Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia; School of Medicine, University of Queensland, Australia.
  • Lawrence Wing Chi Chan
    Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong. Electronic address: wing.chi.chan@polyu.edu.hk.